Loading…
Based on limited metadata, the FDA issued a Warning Letter to Soothedrawal, Inc. on January 11, 2018, regarding a product classified as "Other," though specific details about the product type and regulatory violations are not available from the metadata provided. Without access to the full letter text or subject line, the exact nature of the compliance issues cannot be determined. The issuing FDA office is also not specified in the available information, limiting clarity on which regulatory division oversaw this enforcement action.